Hamlet BioPharma AB engages in the research and development of pharmaceutical products focusing on tumor cells. The company was founded by Catharina Svanborg on March 29, 1999 and is headquartered in Lund, Sweden.
The current price of HAMLET.B is 2.35 SEK — it has increased by 0.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange HAMLET BIOPHARMA AB SER. B stocks are traded under the ticker HAMLET.B.
HAMLET.B stock is 3.91% volatile and has beta coefficient of 0.29. Check out the list of the most volatile stocks — is HAMLET BIOPHARMA AB SER. B there?
HAMLET.B stock has risen by 4.44% compared to the previous week, the month change is a 25.67% rise, over the last year HAMLET BIOPHARMA AB SER. B has showed a 27.24% decrease.
HAMLET.B net income for the last quarter is −9.15 M SEK, while the quarter before that showed −8.83 M SEK of net income which accounts for −3.69% change. Track more HAMLET BIOPHARMA AB SER. B financial stats to get the full picture.
Today HAMLET BIOPHARMA AB SER. B has the market capitalization of 392.58 M, it has increased by 7.66% over the last week.
No, HAMLET.B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HAMLET.B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HAMLET BIOPHARMA AB SER. B stock right from TradingView charts — choose your broker and connect to your account.
HAMLET.B reached its all-time high on Jul 19, 2019 with the price of 19.87 SEK, and its all-time low was 1.00 SEK and was reached on Nov 28, 2023. See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 4.00 employees. See our rating of the largest employees — is HAMLET BIOPHARMA AB SER. B on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HAMLET BIOPHARMA AB SER. B technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HAMLET BIOPHARMA AB SER. B stock shows the neutral signal. See more of HAMLET BIOPHARMA AB SER. B technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.